Retraction Note To: Suppression of the xCT–CD44v Antiporter System Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-015-3399-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy